Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey
Why is gene therapy still so difficult to manufacture at scale after decades of progress?
Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversation about one of the central challenges facing advanced therapies: turning extraordinary science into reproducible, scalable medicines.
Thank You to Our Sponsors
Leucentra - https://leucentra.com/
Inspired by Science. Empowered by IT. Leucentra provides specialized IT consulting and services for life sciences and healthcare, helping organizations use technology more effectively to support…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.